The restructuring events database contains factsheets with data on large-scale restructuring events reported in the principal national media and company websites in each EU Member State. This database was created in 2002.
Manufacturing Manufacture Of Chemicals And Pharamceuticals Manufacture Of Basic Pharmaceutical Products And Pharmaceutical Preparations 21 - Manufacture of basic pharmaceutical products and pharmaceutical preparations
330 jobs Number of planned job losses
Announcement Date
28 November 2012
Employment effect (start)
1 December 2012
Foreseen end date
31 December 2012
Description
On 28 November 2012, Polish pharmaceutical company Adamed announced plans to cut a further 330 jobs by the end of 2012.
According to reports, 2500 pharmaceutical employees have been recently dismissed in Poland and there are fears that the number could rise to 3000, if there are more dismissals in the first quarter of 2013. The dismissals are attributed to the crisis that has affected pharmaceutical market.
Adamed was founded in 1986. The company has factories in Ksawerów (the Åódź Special Economic Zone) and in Pabianice.
Sources
28 November 2012: Puls Biznesu ()
Citation
Eurofound (2012), Adamed, Internal restructuring in Poland, factsheet number 74680, European Restructuring Monitor. Dublin, https://restructuringeventsprod.azurewebsites.net/restructuring-events/detail/74680.
Digitisation and automation technologies, including artificial intelligence (AI), can affect working conditions in a variety of ways and their use in the workplace raises a host of new ethical concerns.
The retail banking sector is fertile ground for studying the impacts of digitalisation on work and employment. Financial services are increasingly provided online, without the intermediary of customer-facing institutions.
European labour markets have recovered strongly from COVID-19. By the end of 2021, little more than 18 months after the start of the pandemic, employment rates in the EU were almost at pre-crisis levels.
